Ataraxis

formerly Ataraxis AI

Transforming Cancer Care with AI Precision Medicine

New York, United States · Founded 2022 · $24.4M raised

Headquarters
New York, New York
Employees
11–50
Founded
2022
Business Model
B2B
Total Funding
$24.4M
Last Round
$20.4M Series AMar 2025
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Ataraxis AI is an AI precision medicine company building foundation models for oncology that empower physicians to personalize cancer treatment. Their flagship product, Ataraxis Breast, is the first clinically available AI-native breast cancer platform that analyzes multi-modal patient data to predict outcomes and guide treatment selection, reducing unnecessary chemotherapy.

Summary

Ataraxis is an Artificial Intelligence company based in New York, United States, founded in 2022. It has raised $24.4M in total across 2 rounds, most recently a $20.4M Series A round in Mar 2025. Investors include Giant Ventures, Obvious Ventures and AIX Ventures.

Tech & App Stack

9 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AMar 2025
$20.4M

Sign up to see all 2 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Ataraxis on Indexed.vc
<a href="https://indexed.vc/companies/ataraxis"><img src="https://indexed.vc/api/badge/company/ataraxis" alt="Ataraxis on Indexed.vc" width="260" height="76" /></a>